Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Biochem Mol Toxicol ; 37(11): e23454, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37409753

ABSTRACT

In spite of recent advances made in understanding its progression, cancer is still a leading cause of death across the nations. Molecular pathophysiology of these cancer cells largely differs depending on cancer types and even within the same tumor. Pathological mineralization/calcification is seen in various tissues including breast, prostate, and lung cancer. Osteoblast-like cells derived after trans-differentiation of mesenchymal cells usually drive calcium deposition in various tissues. This study aims to explore the presence of osteoblast-like potential in lung cancer cells and its prevention. ALP assay, ALP staining, nodule formation, RT-PCR, RT-qPCR, and western blot analysis experiments were carried out in lung cancer A549 cells to achieve said objective. Expressions of various osteoblast markers (e.g., ALP, OPN, RUNX2, and Osterix) along with osteoinducer genes (BMP-2 and BMP-4) were observed in A549 cells. Moreover, ALP activity and ability leading to nodule formation revealed the presence of osteoblast-like potential in lung cancer cells. Here, BMP-2 treatment increased expressions of osteoblast transcription factors such as RUNX2 and Osterix, enhanced ALP activity, and augmented calcification in this cell line. It was also observed that antidiabetic metformin inhibited BMP-2 mediated increase in osteoblast-like potential and calcification in these cancer cells. The current study noted that metformin blocked BMP-2 mediated increase in epithelial to mesenchymal transition (EMT) in A549 cells. The above findings for the first time unravel that A549 cells possess osteoblast-like potential which drives lung cancer calcification. Metformin might prevent BMP-2 induced osteoblast-like phenotype of the lung cancer cells with concomitant inhibition of EMT to inhibit lung cancer tissue calcification.


Subject(s)
Lung Neoplasms , Metformin , Male , Humans , Core Binding Factor Alpha 1 Subunit/genetics , Core Binding Factor Alpha 1 Subunit/metabolism , Lung Neoplasms/metabolism , Epithelial-Mesenchymal Transition , Metformin/pharmacology , A549 Cells , Cell Differentiation , Osteoblasts/metabolism , Osteogenesis
2.
Carbohydr Polym ; 227: 115303, 2020 Jan 01.
Article in English | MEDLINE | ID: mdl-31590852

ABSTRACT

The potential of citric acid (CA) included as a crosslinker for development of CMC-PVA films with better mechanical and lower solubility was examined. To make functional active packaging films for storage of perishable food products, the role of Aloe vera (AV) was also investigated. Addition of CA effectively improved the mechanical properties, reduced the water solubility, moisture content and water vapour permeability of the film. FTIR analysis confirmed that incorporation of CA led to formation of ester bonds and hence cross linking. AV the active component of the composite film, didn't interfere with the barrier properties of the film and served as a protector against UV light. The film delayed lipid peroxidation and microbial growth of packaged minced chicken meat. Thus, incorporation of CA and AV were efficacious in developing an eco-friendly, water-resistant active packaging film that extended the shelf-life of minced meat.

SELECTION OF CITATIONS
SEARCH DETAIL